{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:05Z","timestamp":1791979085082,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-002-126-MY3"],"award-info":[{"award-number":["113-2314-B-002-126-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-002-217-MY3"],"award-info":[{"award-number":["114-2314-B-002-217-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW113-TDU-B-211-114006"],"award-info":[{"award-number":["MOHW113-TDU-B-211-114006"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-SS0012"],"award-info":[{"award-number":["114-SS0012"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["115-SS0026"],"award-info":[{"award-number":["115-SS0026"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["115-TMU112"],"award-info":[{"award-number":["115-TMU112"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["CTC115(MQ999)"],"award-info":[{"award-number":["CTC115(MQ999)"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40121-026-01369-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:59:42Z","timestamp":1779461982000},"page":"1925-1937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12\u00a0mg\/kg"],"prefix":"10.1007","volume":"15","author":[{"given":"Luo-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-8276","authenticated-orcid":false,"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"4","key":"1369_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant Enterococci. Clin Microbiol Rev. 2000;13(4):686\u2013707. https:\/\/doi.org\/10.1128\/CMR.13.4.686.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"1369_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00059-22","volume":"36","author":"KA Cairns","year":"2023","unstructured":"Cairns KA, Udy AA, Peel TN, Abbott IJ, Dooley MJ, Peleg AY. Therapeutics for vancomycin-resistant enterococcal bloodstream infections. Clin Microbiol Rev. 2023;36(2):e0005922. https:\/\/doi.org\/10.1128\/cmr.00059-22.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"1369_CR3","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis. 2004;38(12):1673\u201381. https:\/\/doi.org\/10.1086\/420818.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1369_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0589-2","volume":"19","author":"RM Kohinke","year":"2017","unstructured":"Kohinke RM, Pakyz AL. Treatment of vancomycin-resistant enterococci: focus on daptomycin. Curr Infect Dis Rep. 2017;19(10):33. https:\/\/doi.org\/10.1007\/s11908-017-0589-2.","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"1369_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01289-13","volume":"58","author":"EP Balli","year":"2014","unstructured":"Balli EP, Venetis CA, Miyakis S. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother. 2014;58(2):734\u20139. https:\/\/doi.org\/10.1128\/AAC.01289-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1369_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0687-9","volume":"14","author":"YC Chuang","year":"2014","unstructured":"Chuang YC, Wang JT, Lin HY, Chang SC. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect Dis. 2014;14(1):687. https:\/\/doi.org\/10.1186\/s12879-014-0687-9.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1369_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/cid\/civ444","volume":"61","author":"NS Britt","year":"2015","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015;61(6):871\u20138. https:\/\/doi.org\/10.1093\/cid\/civ444.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1369_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/cid\/ciw815","volume":"64","author":"NS Britt","year":"2017","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparative effectiveness and safety of standard-, medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients. Clin Infect Dis. 2017;64(5):605\u201313. https:\/\/doi.org\/10.1093\/cid\/ciw815.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1369_CR9","doi-asserted-by":"publisher","first-page":"890 e1","DOI":"10.1016\/j.cmi.2016.07.018","volume":"22","author":"YC Chuang","year":"2016","unstructured":"Chuang YC, Lin HY, Chen PY, Lin CY, Wang JT, Chang SC. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clin Microbiol Infect. 2016;22(10):890 e1-e7. https:\/\/doi.org\/10.1016\/j.cmi.2016.07.018.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1369_CR10","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/jac\/dkac164","volume":"77","author":"YC Chuang","year":"2022","unstructured":"Chuang YC, Lin HY, Yang JL, et al. Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin. J Antimicrob Chemother. 2022;77(8):2278\u201387. https:\/\/doi.org\/10.1093\/jac\/dkac164.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1369_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cix024","volume":"64","author":"YC Chuang","year":"2017","unstructured":"Chuang YC, Lin HY, Chen PY, et al. Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis. 2017;64(8):1026\u201334. https:\/\/doi.org\/10.1093\/cid\/cix024.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1369_CR12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","volume":"26","author":"J Turnidge","year":"2020","unstructured":"Turnidge J, Kahlmeter G, Canton R, MacGowan A, Giske CG, European Committee on Antimicrobial Susceptibility T. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. Clin Microbiol Infect. 2020;26(8):1039\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.027.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1369_CR13","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/cid\/ciy749","volume":"68","author":"LM Avery","year":"2019","unstructured":"Avery LM, Kuti JL, Weisser M, et al. Pharmacodynamic analysis of daptomycin-treated enterococcal bacteremia: it is time to change the breakpoint. Clin Infect Dis. 2019;68(10):1650\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy749.","journal-title":"Clin Infect Dis"},{"key":"1369_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113710","volume":"155","author":"YC Chuang","year":"2022","unstructured":"Chuang YC, Lin HY, Wang JT, et al. Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection. Biomed Pharmacother. 2022;155:113710. https:\/\/doi.org\/10.1016\/j.biopha.2022.113710.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1369_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijantimicag.2013.05.005","volume":"42","author":"IM Gould","year":"2013","unstructured":"Gould IM, Miro JM, Rybak MJ. Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. Int J Antimicrob Agents. 2013;42(3):202\u201310. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.05.005.","journal-title":"Int J Antimicrob Agents"},{"key":"1369_CR16","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.2147\/IDR.S570238","volume":"18","author":"CJ Yang","year":"2025","unstructured":"Yang CJ, Wang JT, Yang JL, Chuang YC. Comparative efficacy of high-dose daptomycin monotherapy versus combination therapy for daptomycin-resistant Enterococcus faecium endocarditis in a rat model. Infect Drug Resist. 2025;18:6865\u201374. https:\/\/doi.org\/10.2147\/IDR.S570238.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"1369_CR17","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/jac\/dky072","volume":"73","author":"F Foolad","year":"2018","unstructured":"Foolad F, Taylor BD, Shelburne SA, Arias CA, Aitken SL. Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review. J Antimicrob Chemother. 2018;73(9):2277\u201383. https:\/\/doi.org\/10.1093\/jac\/dky072.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1369_CR18","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/bcp.15671","volume":"89","author":"M Samura","year":"2023","unstructured":"Samura M, Takada K, Hirose N, et al. Comparison of the efficacy and safety of standard- and high-dose daptomycin: a systematic review and meta-analysis. Br J Clin Pharmacol. 2023;89(4):1291\u2013303. https:\/\/doi.org\/10.1111\/bcp.15671.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1369_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijantimicag.2011.03.006","volume":"38","author":"G Wu","year":"2011","unstructured":"Wu G, Abraham T, Rapp J, Vastey F, Saad N, Balmir E. Daptomycin: evaluation of a high-dose treatment strategy. Int J Antimicrob Agents. 2011;38(3):192\u20136. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.03.006.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"1369_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000109868","volume":"81","author":"R Sauermann","year":"2008","unstructured":"Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: a review 4 years after first approval. Pharmacology. 2008;81(2):79\u201391. https:\/\/doi.org\/10.1159\/000109868.","journal-title":"Pharmacology"},{"issue":"12","key":"1369_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12325-015-0267-4","volume":"32","author":"RA Seaton","year":"2015","unstructured":"Seaton RA, Menichetti F, Dalekos G, et al. Evaluation of effectiveness and safety of high-dose daptomycin: results from patients included in the European Cubicin((R)) outcomes registry and experience. Adv Ther. 2015;32(12):1192\u2013205. https:\/\/doi.org\/10.1007\/s12325-015-0267-4.","journal-title":"Adv Ther"},{"issue":"12","key":"1369_CR22","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/652767","volume":"50","author":"SM Bhavnani","year":"2010","unstructured":"Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin Infect Dis. 2010;50(12):1568\u201374. https:\/\/doi.org\/10.1086\/652767.","journal-title":"Clin Infect Dis"},{"key":"1369_CR23","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2026","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 36th ed. Wayne: CLSI; 2026.","edition":"36"},{"issue":"5","key":"1369_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002.","journal-title":"Am J Infect Control"},{"issue":"9","key":"1369_CR25","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1093\/cid\/cir257","volume":"52","author":"NP O'Grady","year":"2011","unstructured":"O\u2019Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93. https:\/\/doi.org\/10.1093\/cid\/cir257.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1369_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"1","key":"1369_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0924-8579(98)00060-0","volume":"11","author":"JW Chow","year":"1999","unstructured":"Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999;11(1):7\u201312. https:\/\/doi.org\/10.1016\/s0924-8579(98)00060-0.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1369_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/cid\/ciq154","volume":"52","author":"YC Chuang","year":"2011","unstructured":"Chuang YC, Sheng WH, Li SY, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis. 2011;52(3):352\u201360. https:\/\/doi.org\/10.1093\/cid\/ciq154.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1369_CR29","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/AAC.00247-06","volume":"50","author":"M Benvenuto","year":"2006","unstructured":"Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50(10):3245\u20139. https:\/\/doi.org\/10.1128\/AAC.00247-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"1369_CR30","volume-title":"Clinical pharmacokinetics and pharmacodynamics: concepts and applications","author":"M Rowland","year":"2019","unstructured":"Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. 5th ed. Philadelphia: Wolters Kluwer Health; 2019.","edition":"5"},{"key":"1369_CR31","volume-title":"Pharmacokinetic and pharmacodynamic data analysis: concepts and applications","author":"J Gabrielsson","year":"2016","unstructured":"Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 5th ed. Stockholm: Swedish Pharmaceutical Press; 2016.","edition":"5"},{"issue":"1","key":"1369_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-66","volume":"13","author":"CC Lai","year":"2013","unstructured":"Lai CC, Sheng WH, Wang JT, et al. Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients. BMC Infect Dis. 2013;13(1):66. https:\/\/doi.org\/10.1186\/1471-2334-13-66.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1369_CR33","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"1369_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac577","volume":"9","author":"TT Pham","year":"2022","unstructured":"Pham TT, Garreau R, Craighero F, et al. Seventeen cases of daptomycin-induced eosinophilic pneumonia in a cohort of patients treated for bone and joint infections: proposal for a new algorithm. Open Forum Infect Dis. 2022;9(11):ofac577. https:\/\/doi.org\/10.1093\/ofid\/ofac577.","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 1(Supplem","key":"1369_CR35","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1086\/647938","volume":"50","author":"BI Eisenstein","year":"2010","unstructured":"Eisenstein BI, Oleson FB Jr., Baltz RH. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010;50(Suppl 1(Supplement_1)):S10-5. https:\/\/doi.org\/10.1086\/647938.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1369_CR36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","volume":"47","author":"BH Dvorchik","year":"2003","unstructured":"Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 2003;47(4):1318\u201323. https:\/\/doi.org\/10.1128\/AAC.47.4.1318-1323.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"1369_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0158-8","volume":"5","author":"P Uppal","year":"2016","unstructured":"Uppal P, LaPlante KL, Gaitanis MM, Jankowich MD, Ward KE. Daptomycin-induced eosinophilic pneumonia\u2014a systematic review. Antimicrob Resist Infect Control. 2016;5:55. https:\/\/doi.org\/10.1186\/s13756-016-0158-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"1369_CR38","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1086\/430352","volume":"191","author":"JA Silverman","year":"2005","unstructured":"Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191(12):2149\u201352. https:\/\/doi.org\/10.1086\/430352.","journal-title":"J Infect Dis"},{"issue":"8","key":"1369_CR39","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/cid\/ciac128","volume":"75","author":"M Chuma","year":"2022","unstructured":"Chuma M, Nakamoto A, Bando T, et al. Association between statin use and daptomycin-related musculoskeletal adverse events: a mixed approach combining a meta-analysis and a disproportionality analysis. Clin Infect Dis. 2022;75(8):1416\u201322. https:\/\/doi.org\/10.1093\/cid\/ciac128.","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01369-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:33:17Z","timestamp":1781803997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01369-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Luo-Wei Lin, Yu-Chung Chuang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yee-Chun Chen, and Shan-Chwen Chang declare that they have no conflict of interest relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Research Ethics Committee of National Taiwan University Hospital (NTUH-REC No. 202601207RIND). The requirement for informed consent was waived by NTUH-REC given its retrospective analysis design, importance of populational values, and minimal risks to participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}